Scandinavian Health Limited selects NetDimensions Learning for regulatory compliance training
Hong Kong- March 28, 2017 – NetDimensions announced today that Scandinavian Health Limited (SHL) has selected NetDimensions Learning to replace paper-based processes and enhance training plan management for consistent implementation of standards and regulatory requirements across SHL companies worldwide.
"We are very pleased to partner with the SHL Group to help improve and streamline their training and employee development programmes, which are critical to the company's branding initiatives and employee retention," noted Jay Shaw, Managing Director and CEO at NetDimensions.
To keep pace with the speed of growth of its business and employee numbers, as well as to improve efficiency and quality of administrative processes and management of training records, SHL Group needed a robust, centralised solution for training and employee development.
SHL selected NetDimensions Learning because of its proven usability, availability of data exchange interfaces requiring no customisation, scalability and ease of integration with existing IT solutions, as well as competent support and consultancy by the NetDimensions team.
Lillian Yao, HR Director at SHL Taiwan said: "The NetDimensions consulting team provided great support during the system requirements gathering process, as well as works proactively and digs into various possible solution scenarios to support all operational and organisational needs of SHL's learning management. We are looking forward to further fruitful and successful cooperation."
About Scandinavian Health Limited
SHL Group (SHL) is the world's largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. The company has over 3,000 staff globally, with primary design centres located in the USA and Sweden and manufacturing centres located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced the Group’s broad pipeline of "next generation" drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
The SHL Group organisation consists of several distinct group companies:
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
Develops and manufactures equipment solutions for home, hospital and long term care use
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com.